Literature DB >> 11717608

A simplified approach for assessment of intracardiac baffles and extracardiac conduits in congenital heart surgery with two- and three-dimensional magnetic resonance imaging.

M A Fogel1, A Hubbard, P M Weinberg.   

Abstract

BACKGROUND: Intracardiac baffles and extracardiac conduits have been used in the reconstructive surgery of a broad spectrum of congenital cardiac malformations. Periodic evaluation of these structures may not lend itself readily to echocardiographic and angiographic imaging. The purpose of the study was to describe the experience of our institution with the use of magnetic resonance imaging (MRI) in evaluating conduits and baffles and to describe the simplified approach we developed to image these structures, which allows for grouping individual lesions into broad categories. METHODS AND
RESULTS: We retrospectively reviewed our MRI experience in visualizing these structures from 1989-1996. One hundred thirty-nine patients underwent MRI to visualize 144 structures (116 baffles, 28 conduits). The 116 baffles included 86 Fontan, 16 Mustard, 6 Senning, 6 left ventricle to aorta, 1 right ventricle to aorta, and 1 pulmonary vein to left atrium baffle. The 28 conduits included 15 right ventricle to pulmonary artery, 4 left ventricular apical to aorta, 2 left ventricle to pulmonary artery, 3 aorta to aorta, 2 inferior vena cava to left atrium conduits, and 2 aortic root replacements. Of the 3 aortic-aortic conduits, 1 was in conjoined twins. Both inferior vena cava-left atrial conduits were in a Baffes procedure. An infectious mass missed by echocardiography in a right ventricle to pulmonary artery conduit was visualized by MRI. With multiplanar reconstruction, contiguous images were stacked atop each other and resliced to define the salient points of the anatomy. Three-dimensional reconstruction further added to this delineation. All structures were visualized successfully, and an assessment of obstruction was made. Multiple examples of conduit and baffle narrowing were diagnosed by spin echo and cine MRI and were subsequently confirmed by catheterization and surgical inspection.
CONCLUSION: MRI, with multiplanar and 3-dimensional reconstruction, is useful in examining the variety of baffles and conduits used in congenital heart surgery. MRI can add to the care of patients whose echocardiographic windows or whose angiographically overlapping structures do not allow adequate delineation of conduits and baffles.

Entities:  

Mesh:

Year:  2001        PMID: 11717608     DOI: 10.1067/mhj.2001.118469

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

Review 1.  When to order cardiovascular magnetic resonance in adults with congenital heart disease.

Authors:  Sonya V Babu-Narayan; Philip J Kilner; Michael A Gatzoulis
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

2.  Right aortic arch and coarctation: a rare association.

Authors:  Fraz A Ismat; Paul M Weinberg; Jack Rychik; Tom R Karl; Mark A Fogel
Journal:  Congenit Heart Dis       Date:  2006-09       Impact factor: 2.007

3.  In vivo MRI measurement of blood oxygen saturation in children with congenital heart disease.

Authors:  Lynne E Nield; Xiu-Ling L Qi; Emanuela R Valsangiacomo; Christopher K Macgowan; Graham A Wright; Lisa K Hornberger; Shi-Joon Yoo
Journal:  Pediatr Radiol       Date:  2004-10-14

Review 4.  Transposition of the great arteries: long-term outcome and current management.

Authors:  Daniel J Murphy
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 6.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

7.  Cardiac MRI in the management of congenital heart disease in children, adolescents, and young adults.

Authors:  Pamela K Woodard; Sanjeev Bhalla; Cylen Javidan-Nejad; Andrew Bierhals; Fernando R Gutierrez; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

8.  Factors impacting echocardiographic imaging after the Fontan procedure: a report from the pediatric heart network fontan cross-sectional study.

Authors:  Richard V Williams; Renee Margossian; Minmin Lu; Andrew M Atz; Timothy J Bradley; Michael Jay Campbell; Steven D Colan; Dianne Gallagher; Wyman W Lai; Gail D Pearson; Ashwin Prakash; Girish Shirali; Meryl S Cohen
Journal:  Echocardiography       Date:  2013-04-25       Impact factor: 1.724

Review 9.  Advances in fetal cardiac imaging.

Authors:  M Sklansky
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

Review 10.  SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.

Authors:  Tim Leiner; Jan Bogaert; Matthias G Friedrich; Raad Mohiaddin; Vivek Muthurangu; Saul Myerson; Andrew J Powell; Subha V Raman; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2020-11-09       Impact factor: 5.364

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.